Beijing Foyou Pharma (601089.SH) has received the registration certificate for Diclofenac Diethylamine Emulsion.
Fuyuan Medical (601089.SH) issued an announcement, its wholly-owned subsidiary Fuyuan Pharmaceutical Co., Ltd. (referred to as "Fuyuan...
Beijing Foyou Pharma (601089.SH) announced that its wholly-owned subsidiary, Fuyuan Pharmaceutical Co., Ltd. (referred to as "Fuyuan Pharma"), has received the "Drug Registration Certificate" for the Diclofenac Diethylamine Emulgel [Specification: 1% (20g: 0.2g, calculated as Diclofenac Sodium)] issued by the National Medical Products Administration (Certificate Number: 2025S00011). It is used to relieve mild to moderate pain in muscles, soft tissues, and joints.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


